Infographic | March 16, 2021

Small Molecule Drug Substance Outsourcing Drivers By Company Size

Source: ISR Reports

In Q42020, ISR surveyed 123 sponsors who outsource small molecule drug substance manufacturing to learn more about their primary reason for outsourcing. The data show that sponsors from large pharma tend to use CMOs to augment internal manufacturing capacity (68%) while sponsors from non-large pharma use CMOs for all manufacturing needs (79%). To learn more, follow the link to the Small Molecule API Contract Manufacturer Quality Benchmarking report preview.

VIEW THE INFOGRAPHIC!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online